• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015年前列腺癌分级组在共享平等获取医疗系统中预测长期肿瘤学结局的验证

Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.

作者信息

Schulman Ariel A, Howard Lauren E, Tay Kae Jack, Tsivian Efrat, Sze Christina, Amling Christopher L, Aronson William J, Cooperberg Matthew R, Kane Christopher J, Terris Martha K, Freedland Stephen J, Polascik Thomas J

机构信息

Division of Urology, Duke University Medical Center, Durham, North Carolina.

Surgery Section, Durham Veterans Affairs Medical Center, Durham, North Carolina.

出版信息

Cancer. 2017 Nov 1;123(21):4122-4129. doi: 10.1002/cncr.30844. Epub 2017 Jun 29.

DOI:10.1002/cncr.30844
PMID:28662291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6986737/
Abstract

BACKGROUND

A 5-tier prognostic grade group (GG) system was enacted to simplify the risk stratification of patients with prostate cancer in which Gleason scores of ≤6, 3 + 4, 4 + 3, 8, and 9 or 10 are considered GG 1 through 5, respectively. The authors investigated the utility of biopsy GG for predicting long-term oncologic outcomes after radical prostatectomy in an equal-access health system.

METHODS

Men who underwent prostatectomy at 1 of 6 Veterans Affairs hospitals in the Shared Equal Access Regional Cancer Hospital database between 2005 and 2015 were reviewed. The prognostic ability of biopsy GG was examined using Cox models. Interactions between GG and race also were tested.

RESULTS

In total, 2509 men were identified who had data available on biopsy Gleason scores, covariates, and follow-up. The cohort included men with GG 1 (909 patients; 36.2%), GG 2 (813 patients; 32.4%), GG 3 (398 patients; 15.9%), GG 4 (279 patients; 11.1%), and GG 5 (110 patients; 4.4%) prostate cancer. The cohort included 1002 African American men (41%). The median follow-up was 60 months (interquartile range, 33-90 months). Higher GG was associated with higher clinical stage, older age, more recent surgery, and surgical center (P < .001) as well as increased biochemical recurrence, secondary therapy, castration-resistant prostate cancer, metastases, and prostate cancer-specific mortality (all P < .001). There were no significant interactions with race in predicting measured outcomes.

CONCLUSIONS

The 5-tier GG system predicted multiple long-term endpoints after radical prostatectomy in an equal-access health system. The predictive value was consistent across races. Cancer 2017;123:4122-4129. © 2017 American Cancer Society.

摘要

背景

制定了一个5级预后分级组(GG)系统,以简化前列腺癌患者的风险分层,其中 Gleason 评分≤6、3 + 4、4 + 3、8以及9或10分别被视为GG 1至5级。作者在一个平等医疗的卫生系统中,研究了活检GG分级对预测根治性前列腺切除术后长期肿瘤学结局的效用。

方法

回顾了2005年至2015年期间在共享平等医疗区域癌症医院数据库中6家退伍军人事务医院之一接受前列腺切除术的男性患者。使用Cox模型检验活检GG分级的预后能力。还测试了GG分级与种族之间的相互作用。

结果

总共确定了2509名男性患者,他们有关于活检Gleason评分、协变量和随访的数据。该队列包括GG 1级(909例患者;36.2%)、GG 2级(813例患者;32.4%)、GG 3级(398例患者;15.9%)、GG 4级(279例患者;11.1%)和GG 5级(110例患者;4.4%)的前列腺癌患者。该队列包括1002名非裔美国男性(41%)。中位随访时间为60个月(四分位间距,33 - 90个月)。较高的GG分级与更高的临床分期、年龄较大、手术时间更近以及手术中心相关(P <.001),同时生化复发、二次治疗、去势抵抗性前列腺癌、转移和前列腺癌特异性死亡率增加(所有P <.001)。在预测测量结局方面,与种族没有显著的相互作用。

结论

在一个平等医疗的卫生系统中,5级GG系统预测了根治性前列腺切除术后的多个长期终点。预测价值在不同种族中是一致的。《癌症》2017年;123:4122 - 4129。© 2017美国癌症协会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce17/6986737/d9655aeb01f9/nihms-1063907-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce17/6986737/3134b5bb1f25/nihms-1063907-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce17/6986737/d9655aeb01f9/nihms-1063907-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce17/6986737/3134b5bb1f25/nihms-1063907-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce17/6986737/d9655aeb01f9/nihms-1063907-f0002.jpg

相似文献

1
Validation of the 2015 prostate cancer grade groups for predicting long-term oncologic outcomes in a shared equal-access health system.2015年前列腺癌分级组在共享平等获取医疗系统中预测长期肿瘤学结局的验证
Cancer. 2017 Nov 1;123(21):4122-4129. doi: 10.1002/cncr.30844. Epub 2017 Jun 29.
2
Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.种族与前列腺癌根治术后转移风险及生存情况:来自SEARCH数据库的结果
Cancer. 2017 Nov 1;123(21):4199-4206. doi: 10.1002/cncr.30834. Epub 2017 Jun 27.
3
Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.前列腺特异性抗原水平、分期或 Gleason 评分:哪一项最适合预测根治性前列腺切除术后的结果,并且它是否因所测量的结果而异?来自共享平等访问区域癌症医院数据库的结果。
Int J Urol. 2015 Apr;22(4):362-6. doi: 10.1111/iju.12704. Epub 2015 Feb 24.
4
African-American men with low-risk prostate cancer treated with radical prostatectomy in an equal-access health care system: implications for active surveillance.在一个平等获得医疗保健的体系中,接受根治性前列腺切除术治疗低危前列腺癌的非裔美国男性:对主动监测的影响。
Prostate Cancer Prostatic Dis. 2020 Dec;23(4):581-588. doi: 10.1038/s41391-020-0230-6. Epub 2020 Apr 23.
5
Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.前列腺癌根治术后种族作为预后预测指标:来自共享平等医疗区域癌症医院(SEARCH)数据库的结果
Urology. 2002 Oct;60(4):670-4. doi: 10.1016/s0090-4295(02)01847-2.
6
Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.在一个医疗机会均等的中心,种族并非根治性前列腺切除术后生化复发的独立预测因素。
Urology. 2000 Jul;56(1):87-91. doi: 10.1016/s0090-4295(00)00587-2.
7
Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.黑人与白人中等级分组 4 或 5(Gleason 评分 8-10)前列腺癌患者,经根治性前列腺切除术治疗后的肿瘤学结局。
Cancer. 2021 May 1;127(9):1425-1431. doi: 10.1002/cncr.33419. Epub 2021 Mar 15.
8
Validation of a genomic classifier for prediction of metastasis and prostate cancer-specific mortality in African-American men following radical prostatectomy in an equal access healthcare setting.在公平医疗保健环境下,对接受根治性前列腺切除术的非裔美国男性进行的基因组分类器预测转移和前列腺癌特异性死亡率的验证。
Prostate Cancer Prostatic Dis. 2020 Sep;23(3):419-428. doi: 10.1038/s41391-019-0197-3. Epub 2019 Dec 16.
9
Gleason grade grouping of prostate cancer is of prognostic value in Asian men.前列腺癌的Gleason分级分组对亚洲男性具有预后价值。
J Clin Pathol. 2017 Sep;70(9):745-753. doi: 10.1136/jclinpath-2016-204276. Epub 2017 Mar 13.
10
Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy.在接受根治性前列腺切除术的 Gleason 7 前列腺癌患者中,阳性切缘的主要 Gleason 分级 4 与转移和死亡相关。
Eur Urol. 2014 Dec;66(6):1116-24. doi: 10.1016/j.eururo.2014.07.004. Epub 2014 Jul 19.

引用本文的文献

1
Metabolic syndrome is associated with aggressive prostate cancer regardless of race.代谢综合征与侵袭性前列腺癌有关,与种族无关。
Cancer Causes Control. 2023 Mar;34(3):213-221. doi: 10.1007/s10552-022-01649-9. Epub 2022 Dec 1.
2
Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance.使用多参数磁共振成像和融合引导活检,正确选择和监测接受主动监测的非裔美国男性。
BJU Int. 2019 Nov;124(5):768-774. doi: 10.1111/bju.14835. Epub 2019 Jun 26.
3
The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literature.

本文引用的文献

1
Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study.前列腺癌新分级组的预后价值:一项多机构欧洲验证研究
Prostate Cancer Prostatic Dis. 2017 Jun;20(2):197-202. doi: 10.1038/pcan.2016.66. Epub 2017 Jan 10.
2
Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.应用预后格里森分组系统评估远处前列腺癌结局。
Eur Urol. 2017 May;71(5):750-759. doi: 10.1016/j.eururo.2016.11.032. Epub 2016 Dec 9.
3
Validation of a Contemporary Five-tiered Gleason Grade Grouping Using Population-based Data.
新 ISUP 2014/WHO 2016 前列腺癌分级系统:介绍 5 年后的初步总结和文献系统评价。
World J Urol. 2020 Mar;38(3):657-662. doi: 10.1007/s00345-019-02744-4. Epub 2019 Apr 2.
4
Persistent Homology for the Quantitative Evaluation of Architectural Features in Prostate Cancer Histology.持久同调在前列腺癌组织学中结构特征定量评估中的应用。
Sci Rep. 2019 Feb 4;9(1):1139. doi: 10.1038/s41598-018-36798-y.
5
Future Perspectives and Challenges of Prostate MR Imaging.前列腺磁共振成像的未来展望与挑战
Radiol Clin North Am. 2018 Mar;56(2):327-337. doi: 10.1016/j.rcl.2017.10.013. Epub 2017 Dec 9.
基于人群数据的当代五层 Gleason 分级分组的验证。
Eur Urol. 2017 May;71(5):760-763. doi: 10.1016/j.eururo.2016.11.031. Epub 2016 Dec 7.
4
New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.新的前列腺癌分级系统可预测 Gleason 评分 8-10 级前列腺癌手术后的长期生存情况。
Eur Urol. 2017 Jun;71(6):907-912. doi: 10.1016/j.eururo.2016.11.006. Epub 2016 Nov 19.
5
Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort.在共享平等准入区域癌症医院队列中,根治性前列腺切除术后顶端阳性手术切缘的长期肿瘤学结果。
Prostate Cancer Prostatic Dis. 2016 Dec;19(4):423-428. doi: 10.1038/pcan.2016.45. Epub 2016 Oct 4.
6
Consensus guidelines for reporting prostate cancer Gleason Grade.前列腺癌Gleason分级报告的共识指南。
BJU Int. 2016 Jun;117(6):849. doi: 10.1111/bju.13470.
7
Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome.以前列腺癌死亡为结局对当代前列腺癌分级系统进行验证。
Br J Cancer. 2016 May 10;114(10):1078-83. doi: 10.1038/bjc.2016.86. Epub 2016 Apr 21.
8
Independent surgical validation of the new prostate cancer grade-grouping system.新前列腺癌分级分组系统的独立外科验证
BJU Int. 2016 Nov;118(5):763-769. doi: 10.1111/bju.13488. Epub 2016 Apr 19.
9
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.《2016 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类-第 B 部分:前列腺和膀胱肿瘤》。
Eur Urol. 2016 Jul;70(1):106-119. doi: 10.1016/j.eururo.2016.02.028. Epub 2016 Mar 17.
10
African American Participation in Oncology Clinical Trials--Focus on Prostate Cancer: Implications, Barriers, and Potential Solutions.非裔美国人参与肿瘤学临床试验——以前列腺癌为重点:影响、障碍及潜在解决方案
Clin Genitourin Cancer. 2016 Apr;14(2):105-16. doi: 10.1016/j.clgc.2015.12.003. Epub 2015 Dec 17.